Skip to main content
. 2023 Dec 19;13:22648. doi: 10.1038/s41598-023-49646-5

Figure 1.

Figure 1

Trastuzumab sensitivity of parental and trastuzumab-resistant (TR) cell lines. Parental and TR cell lines were treated with serial concentrations of trastuzumab for 6 days. Cell viability was measured using the Cell Counting Kit-8 assay. Error bars, SD. ***p < 0.001, **p < 0.01, *p < 0.05.